콘텐츠로 건너뛰기
Merck
  • Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.

Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.

Clinical cancer research : an official journal of the American Association for Cancer Research (2001-04-12)
L Panasci, J P Paiement, G Christodoulopoulos, A Belenkov, A Malapetsa, R Aloyz
초록

Various mechanisms have been implicated in nitrogen mustard drug resistance. The role of these mechanisms in the development of chlorambucil drug resistance in chronic lymphocytic leukemia (CLL) is discussed. We review these mechanisms with emphasis on the emerging role of DNA repair, and specifically, recombinational repair. Inhibition of these repair processes may lead to new therapies, not only in CLL, but in other malignancies as well.

MATERIALS
제품 번호
브랜드
제품 설명

Chlorambucil, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Chlorambucil
Chlorambucil for system suitability, European Pharmacopoeia (EP) Reference Standard